Apotex Wins Appelate Reversal In Ofloxacin Case
The U.S. Court of Appeals for the Federal Circuit has reversed a lower court's decision that Canadian generic drug maker Apotex Corp. infringed a patent covering antibacterial ear medicine, ruling that...To view the full article, register now.
Already a subscriber? Click here to view full article